IP Library Granted Patent US 7,479,152
Granted Patent B2
US 7,479,152 · App. 10/885,910 · Granted Jan 20, 2009

Target tissue localization device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,479,152
App. No.
10/885,910
Granted
Jan 20, 2009
Kind
B2
Abstract

A target tissue localization device includes a tubular mesh anchor element that is secured to a placement device. In use, the localization device is passed through the patient's skin to the target tissue, creating a tissue track. The tubular mesh anchor element is located at the target tissue and expanded from a contracted to an expanded configuration. Methods for localizing a lymph node are also described. After determining the position of the lymph node, a localization device, which includes an anchor element, is localized near or within the lymph node. The anchor element is then expanded.

Claims (13)

1. A method for localizing a target tissue, comprising the steps of:

determining the location of the target tissue;

passing a distal end of an elongate localization device through the patient's skin and to the target tissue to create a tissue track between the patient's skin and the target tissue, the localization device comprising a tubular mesh anchor element secured to a placement device, the placement device extending from the tubular mesh anchor element, along the tissue track and through the patient's skin;

locating the tubular mesh anchor element at the target tissue;

expanding the tubular mesh anchor element from a contracted to an expanded configuration; and

wherein the cross-sectional area of the tubular mesh anchor element in the expanded configuration is at least four times the cross-sectional area in the contracted state.

2. The method of claim 1 , further comprising the steps of:

relocating the target tissue using the localization device; and

removing at least a sample of the relocated target tissue.

3. The method of claim 2 , wherein the relocating step is carried out using imaging technology.

4. The method of claim 3 , wherein the imaging technology is selected from the group consisting of ultrasound, thoracoscopy, nuclear medicine, MRI, computed tomography, and plain film.

5. The method of claim 1 , wherein the tubular mesh anchor is positioned on the far side of the target tissue.

6. The method of claim 1 , wherein the tubular mesh anchor is positioned on the near side of the target tissue.

Assignments (3)
SECURITY AGREEMENT Recorded Jul 13, 2010
From: ARTEMIS MEDICAL, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 024672/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2008
From: FULTON, RICHARD EUSTIS, III; DUBRUL, WILLIAM R.
To: GENESIS MEDICAL TECHNOLOGIES, INC.
Reel/Frame 021874/0024 →
CHANGE OF NAME Recorded Nov 21, 2008
From: GENESIS MEDICAL TECHNOLOGIES, INC.
To: ARTEMIS MEDICAL, INC.
Reel/Frame 021874/0307 →